Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study

This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically proven peripheral stage I NSCLC in the period June 2010‐March...

Descripción completa

Detalles Bibliográficos
Autores principales: Saitoh, Jun‐ichi, Shirai, Katsuyuki, Mizukami, Tatsuji, Abe, Takanori, Ebara, Takeshi, Ohno, Tatsuya, Minato, Koichi, Saito, Ryusei, Yamada, Masanobu, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825999/
https://www.ncbi.nlm.nih.gov/pubmed/31532584
http://dx.doi.org/10.1002/cam4.2561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825999/
https://www.ncbi.nlm.nih.gov/pubmed/31532584
http://dx.doi.org/10.1002/cam4.2561

Ejemplares similares